Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nephron. Clinical Practice|April 25, 2009
Kidney disease is a negative predictor of 30-day survival after acute ischaemic strokeSzymon Brzosko, Tomasz Szkolka, Michal Mysliwiec
International Urology and Nephrology|March 16, 2012
Low concentration of heparin used for permanent catheters canal locking is effective and diminishes the risk of bleedingTomasz Hryszko, Szymon Brzosko, Michal Mysliwiec
Atherosclerosis|November 26, 2008
Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal diseaseKrystyna Pawlak, Szymon Brzosko, Michal Mysliwiec, et al.
Atherosclerosis|August 16, 2005
Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysisKrystyna Pawlak, Dariusz Pawlak, Szymon Brzosko, et al.
Archives of Medical Science : AMS|September 20, 2013
Validation of Mini Nutritional Assessment Scale in peritoneal dialysis patientsSzymon Brzosko, Tomasz Hryszko, Mariusz Kłopotowski, et al.
Nephron. Clinical Practice|February 28, 2004
Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective studyTomasz Hryszko, Szymon Brzosko, Maria Mazerska, et al.
American Journal of Nephrology|May 18, 2005
Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipientsJolanta Małyszko, Jacek S Małyszko, Szymon Brzosko, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patientsJolanta Malyszko, Jacek S Malyszko, Szymon Brzosko, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 31, 2012
Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patientsTomasz Hryszko, Alicja Rydzewska-Rosolowska, Szymon Brzosko, et al.
International Urology and Nephrology|August 30, 2011
Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidismTomasz Hryszko, Szymon Brzosko, Alicja Rydzewska-Rosolowska, et al.
Pageof 2